Newsfeed : Study: PRO 2000 Microbicide Fails to Lower HIV Risk

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Newsfeed » December 2009

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


December 14, 2009

Study: PRO 2000 Microbicide Fails to Lower HIV Risk

An international clinical trial has deemed the PRO 2000 vaginal microbicide ineffective as an HIV prevention method, according to the Medical Research Council.

The four-year, placebo-controlled trial by the U.K.-based Microbicides Development Programme (MDP) found that female participants who used PRO 2000 did not have a significantly reduced HIV risk compared with participants who did not use the vaginal gel. The trial enrolled 9,385 women at six research centers in four African countries.

Researchers gave trial participants the vaginal gel along with an HIV prevention package including condoms and sexual health counseling.

“It is unfortunate that this microbicide is ineffective at preventing HIV infection, but it’s still vital for us as scientists to continue to look for new ways of preventing HIV,” said professor Jonathan Weber, cochair of MDP’s program management board. “There are many research groups exploring different avenues to tackle HIV; it is a slow process, but we are making progress.”

However, a South African trial participant said the trial successfully educated women about HIV prevention. “We learned a lot about caring for ourselves, such as using condoms. We also learned to encourage others to test for HIV, and we gained confidence in helping those who were already infected.”

Search: microbicide, PRO 2000, United Kingdom, Africa, Microbicides Development Programme, MDP

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Has a pet helped you deal with your HIV?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.